Clin2
NCT04751331Possibly a fitRecruiting

Study brain response to inflammation in depression

Major Depressive Disorder

Part of Mental health clinical trials.

This early-stage study tests how your brain responds to an “inflammatory challenge” in people with major depressive disorder and in healthy volunteers. It may help researchers understand the immune-to-brain link in depression and guide future treatments.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
180 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are 18–65 years old
  • If you join the depression group, you have moderate-to-severe symptoms (PHQ-9 ≥10 and/or MADRS ≥7)
  • You are in overall good health, including a normal EKG and blood pressure/pulse/temperature on the day of testing
  • You are not pregnant and can follow pregnancy-related safety rules
  • You can safely have MRI scanning (no incompatible metal/implants and you can lie still for 60 minutes)
  • You avoid certain medicines and immune-affecting treatments (for example steroid pills regularly, immune drugs like TNF blockers, and certain anti-inflammatories)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05585047Recruiting
Looking for brain and blood markers in major depression

This study looks at treatment response markers (signs in the body) in people with major depressive disorder (MDD). It may help researchers understand who is more likely to benefit from antidepressant treatment.

Changsha, Hunan
NCT06450704Recruiting
Exercise for depression: brain and body health

This trial tests if a 12-week exercise program can reduce inflammation and improve brain function in people with depression. It's for adults currently taking antidepressant medication and looking for extra help through physical activity.

Alcalá de Henares, Madrid
NCT05644301Recruiting· Phase 3
Blood-marker guided add-on treatment for major depression

This study tests whether doctors can choose the best add-on immune-related treatment for people with major depressive disorder by using inflammation blood tests. It’s meant for people whose depression has not improved enough with their current antidepressant.

Duffel, Antwerpen
NCT05366270Recruiting
Testing how mild heat affects depression symptoms and brain signals

This study tests whether controlled whole-body heat can change immune-related brain and body signals in people with major depressive disorder. It may help researchers understand why heat affects mood and who might benefit, while closely monitoring safety.

Boston, Massachusetts
NCT06080646Recruiting
Depression and Reward Processing Brain Study

This study uses brain scans (MRI) to understand how people with depression process rewards, aiming to identify different depression subtypes. You may join if you have depression or if you are a healthy volunteer.

San Francisco, California
NCT06699966Not yet recruiting· Phase 4
Anti-inflammatory trial for depression

This study tests whether two anti-inflammatory drugs, celecoxib and minocycline, can help treat depression. You may join if you have moderate to severe depression and are not at high risk for certain medical conditions or drug interactions.

Hear when a new Major Depressive Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.